Search Results - "Shimazaki, C"

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis by Kastritis, Efstathios, Palladini, Giovanni, Minnema, Monique C, Wechalekar, Ashutosh D, Jaccard, Arnaud, Lee, Hans C, Sanchorawala, Vaishali, Gibbs, Simon, Mollee, Peter, Venner, Christopher P, Lu, Jin, Schönland, Stefan, Gatt, Moshe E, Suzuki, Kenshi, Kim, Kihyun, Cibeira, M. Teresa, Beksac, Meral, Libby, Edward, Valent, Jason, Hungria, Vania, Wong, Sandy W, Rosenzweig, Michael, Bumma, Naresh, Huart, Antoine, Dimopoulos, Meletios A, Bhutani, Divaya, Waxman, Adam J, Goodman, Stacey A, Zonder, Jeffrey A, Lam, Selay, Song, Kevin, Hansen, Timon, Manier, Salomon, Roeloffzen, Wilfried, Jamroziak, Krzysztof, Kwok, Fiona, Shimazaki, Chihiro, Kim, Jin-Seok, Crusoe, Edvan, Ahmadi, Tahamtan, Tran, NamPhuong, Qin, Xiang, Vasey, Sandra Y, Tromp, Brenda, Schecter, Jordan M, Weiss, Brendan M, Zhuang, Sen H, Vermeulen, Jessica, Merlini, Giampaolo, Comenzo, Raymond L

“…In a randomized trial of bortezomib, cyclophosphamide, and dexamethasone as compared with the same therapy plus daratumumab, patients with light-chain…”
Get full text

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies by Yamamoto, Yukiya, Kiyoi, Hitoshi, Nakano, Yasuyuki, Suzuki, Ritsuro, Kodera, Yoshihisa, Miyawaki, Shuichi, Asou, Norio, Kuriyama, Kazutaka, Yagasaki, Fumiharu, Shimazaki, Chihiro, Akiyama, Hideki, Saito, Kenji, Nishimura, Miki, Motoji, Toshiko, Shinagawa, Katsuji, Takeshita, Akihiro, Saito, Hidehiko, Ueda, Ryuzo, Ohno, Ryuzo, Naoe, Tomoki

“…Mutations of receptor tyrosine kinases are implicated in the constitutive activation and development of human malignancy. An internal tandem duplication (ITD)…”
Get full text

Alteration of Stimulus-Specific Guard Cell Calcium Oscillations and Stomatal Closing in Arabidopsis det3 Mutant by Allen, Gethyn J., Chu, Sarah P., Schumacher, Karin, Shimazaki, Chad T., Vafeados, Dionne, Kemper, Andrea, Hawke, Scott D., Tallman, Gary, Tsien, Roger Y., Harper, Jeffrey F., Chory, Joanne, Schroeder, Julian I.

“…Cytosolic calcium oscillations control signaling in animal cells, whereas in plants their importance remains largely unknown. In wild-type Arabidopsis guard…”
Get full text

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease by Okamoto, M, Okano, A, Akamatsu, S, Ashihara, E, Inaba, T, Takenaka, H, Katoh, N, Kishimoto, S, Shimazaki, C

Get full text

High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation by Shimazaki, C, Uchida, R, Nakano, S, Namura, K, Fuchida, S-i, Okano, A, Okamoto, M, Inaba, T

Get full text

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model by Yao, H, Ashihara, E, Strovel, J W, Nakagawa, Y, Kuroda, J, Nagao, R, Tanaka, R, Yokota, A, Takeuchi, M, Hayashi, Y, Shimazaki, C, Taniwaki, M, Strand, K, Padia, J, Hirai, H, Kimura, S, Maekawa, T

“…Multiple myeloma (MM) is a malignant neoplasm of plasma cells. Although new molecular targeting agents against MM have been developed based on the better…”
Get full text

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia by KIYOI, H, NAOE, T, TAMURA, J, SHIMAZAKI, C, MATSUE, K, KOBAYASHI, H, ARIMA, N, SUZUKI, R, MORISHITA, H, SAITO, H, UEDA, R, OHNO, R, YOKOTA, S, NAKAO, M, MINAMI, S, KURIYAMA, K, TAKESHITA, A, SAITO, K, HASEGAWA, S, SHIMODAIRA, S

“…FLT3 is a member of receptor tyrosine kinases expressed in leukemia cells, as well as in hematopoietic stem cells. Recently, a somatic alteration of the FLT3…”
Get full text

Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD by Kanda, J, Ichinohe, T, Shimazaki, C, Hamaguchi, M, Watanabe, A, Ishida, H, Yoshihara, T, Morimoto, A, Uoshima, N, Adachi, S, Inukai, T, Sawada, A, Oka, K, Itoh, M, Hino, M, Maruya, E, Saji, H, Uchiyama, T, Kodera, Y

Get full text

Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy by NAOE, T, TAGAWA, Y, AKIYAMA, H, MOTOJI, T, NISHIMURA, M, SHINAGAWA, K, UEDA, R, SAITO, H, OHNO, R, KIYOI, H, KODERA, Y, MIYAWAKI, S, ASOU, N, KURIYAMA, K, KUSUMOTO, S, SHIMAZAKI, C, SAITO, K

“…We investigated the prognostic significance of genetic polymorphism in glutathione-S transferase mu 1 (GSTM1), glutathione-S transferase theta 1 (GSTT1),…”
Get full text

Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab by Kusaba, T, Hatta, T, Tanda, S, Kameyama, H, Tamagaki, K, Okigaki, M, Inaba, T, Shimazaki, C, Sasaki, S

“…A 48-year-old man was admitted to our hospital for investigation of mild renal dysfunction. A blood examination revealed mild elevation of creatinine level…”
Get more information

Modified ELISPOT assay may predict T-cell hyporesponsiveness to non-inherited maternal antigens by TANIGUCHI, K., SHIMAZAKI, C., OCHIAI, N., MARUYA, E., AKATSUKA, Y., ASHIHARA, E., MAEKAWA, T., TANIWAKI, M., SAJI, H.

“…Summary Clinical reports have suggested the existence of immunological tolerance to noninherited maternal antigens (NIMA) in human leukocyte antigen (HLA)…”
Get full text

Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia by OCHIAI, N, SHIMAZAKI, C, FUCHIDA, S, OKANO, A, SUMIKUMA, T, ASHIHARA, E, INABA, T, FUJITA, N, MARUYA, E, NAKAGAWA, M

“…A 17-year-old male with chronic myelogenous leukemia in blast crisis received a non-T cell-depleted (TCD) HLA haplo-identical three-loci mismatched…”
Get full text

Isolation and transplantation of highly purified autologous peripheral CD34 progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study by IMAI, Y, CHOU, T, KOIKE, T, KOGAWA, K, HIRAI, H, YOSHIDA, T, TAMURA, K, KISHI, K, HOTTA, T, TOBINAI, K, TANOSAKI, R, MORISHIMA, Y, OGURA, M, SHIMAZAKI, C, TANIWAKI, M, HIRAOKA, A, TANIMOTO, M

“…The purging efficacy of positive selection of autologous CD34+ PBSC with a clinical scale method of magnetic-activated cell sorting system (CliniMACS) was…”
Get full text

The effects of thalidomide on chemotactic migration of multiple myeloma cell lines by FUCHIDA, S.-I., SHIMAZAKI, C., HIRAI, H., AKAMATSU, S., YAMADA, N., UCHIDA, R., OKANO, A., OKAMOTO, M., INABA, T., TANIWAKI, M.

“…Summary We examined the effect of thalidomide and dexamethasone on the migration of multiple myeloma (MM) cell lines, U266, RPMI8226, and NCI‐H929, using…”
Get full text

Loss of the Cyclin-Dependent Kinase 4-Inhibitor (pl6; MTS1) Gene Is Frequent in and Highly Specific to Lymphoid Tumors in Primary Human Hematopoietic Malignancies by Ogawa, Seishi, Hangaishi, Akira, Miyawaki, Syuichi, Hirosawa, Shinsaku, Miura, Yasusada, Takeyama, Kunihiko, Kamada, Nanao, Ohtake, Shigeki, Uike, Naokuni, Shimazaki, Chihiro, Toyama, Keisuke, Hirano, Masami, Mizoguchi, Hideaki, Kobayashi, Yutaka, Furusawa, Shinpei, Saito, Masaki, Emi, Nobuhiko, Yazaki, Yoshio, Ueda, Ryuzo, Hirai, Hisamaru

“…The cyclin-dependent kinase 4-inhibitor (CDK4I; p16; or MTS1) gene has been proposed as a candidate for a tumor-suppressor gene located in chromosome 9p21, a…”
Get full text

Intramuscular edema as a complication of treatment with imatinib by Shimazaki, C, Ochiai, N, Uchida, R, Fuchida, S-I, Okano, A, Ashihara, E, Inaba, T, Fujita, N, Nakagawa, M

“…Leukemia (2003) 17, 804-805. doi:10.1038/sj.leu.2402868…”
Get full text

Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies by YAMASAKI, S, OHNO, Y, NISHIMURA, M, TOKUNAGA, K, GONDO, H, TAKAUE, Y, HARADA, M, MINEISHI, S, TANIGUCHI, S, YOSHIDA, T, HAYASHI, S, OGAWA, H, SHIMAZAKI, C, TAKAHASHI, S, KASAI, M, WAKE, A

“…With the increasing frequency of haploidentical transplantation, it is becoming more important to establish the degree of HLA mismatch that can be accepted. We…”
Get full text

Expression and role of MHC class I-related chain in myeloma cells by Okamoto, M., Inaba, T., Yamada, N., Uchida, R., Fuchida, S-I., Okano, A., Shimazaki, C., Taniwaki, M.

“…The molecular mechanism of natural killer (NK) cell cytotoxicity to myeloma cells remains unclear. We investigated whether MHC class I-related chain (MIC), a…”
Get full text

Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS overt leukemia based on feto-maternal microchimerism by Fuchida, S, Nakano, S, Yamada, N, Uchida, R, Okano, A, Okamoto, M, Maruya, E, Saji, H, Shimazaki, C

Get full text

Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma by OCHIAI, Naoya, YAMADA, Noriko, UCHIDA, Ryo, FUCHIDA, Shin-Ichi, OKANO, Akira, HATSUSE, Mayumi, OKAMOTO, Masashi, ASHIHARA, Eishi, SHIMAZAKI, Chihiro

“…The feasibility and efficacy of a combination of thalidomide, incadronate, and dexamethasone (TID) were studied in 12 patients with relapsed or refractory…”
Get full text